You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤
Overview
In The News
Executives & Employees
Board of Directors
Paths
Recent Transactions
Transaction Advisors
Advisors & Consultants
Clients
Financials
Suppliers
Competitors

Concordia International Corp.

OVERVIEW

Date Founded
2010
Headquarters
277 Lakeshore Road East, Suite 302, Oakville, On L6h 1j9
Type of Company
Public
Industries
Pharmaceuticals
Company Description
Concordia International Corp. is an integrated, specialty healthcare company that focuses on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population. It engages in the development of pharmaceutical products and medical devices. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in Oakville, Canada.
Website

In The News See more

PR Newswire
November 21, 2017
ENP Newswire
November 16, 2017
News Bites Canadian Markets
November 15, 2017
PR Newswire
November 14, 2017
ENP Newswire
November 7, 2017
See full news coverage and complete stories with RelSci Professional.

Executives & Employees


Chief Executive Officer & Director

Chief Financial Officer

Secretary & Chief Legal Officer

Chief Corporate Development Officer

President, North America Segment

President-International Segment
See our list of current and previous employees when you upgrade.

Board of Directors


Former Partner at JJR Private Capital, Inc.

Senior Partner at Deeth Williams Wall LLP

Chief Financial Officer-Life Sciences at Dickinson & Co.

Senior Advisor at INKEF Capital BV

Former Executive Vice President, Finance & Administration & Chief Financial Officer at Forest Laboratories, Inc.

Chief Executive Officer & Director at Concordia International Corp.

Professional at BDO Capital Advisors LLC
See our list of current and previous board members when you upgrade.

Paths to Concordia International Corp.

Concordia International Corp.
You
Connections via Relationship Science
Concordia International Corp.
Sync your contacts to see how you can connect with Concordia International Corp..

Recent Transactions

Details Hidden
Concordia International Corp. purchases Concordia International RX (UK) Ltd. from Cinven Group Ltd., AlpInvest Partners BV
Details Hidden
Concordia International Corp. issued Common Stock
Details Hidden
Concordia International Corp. issued Subscription Receipts
Details Hidden
Concordia International Corp. issued Common Stock
Details Hidden
Mercari Acquisition Corp. purchases Concordia Healthcare, Inc. resulting in a new company Concordia International Corp.

Transaction Advisors

Companies ▾
Legal Advisor
Advised on Concordia International Corp. purchases Concordia International RX (UK) Ltd. from Cinven Group Ltd., AlpInvest Partners BV
Auditor
Advised on Concordia International Corp. issued Common Stock
Escrow Agent
Advised on Concordia International Corp. issued Common Stock
Lead Manager
Advised on Concordia International Corp. issued Subscription Receipts
Investment Advisor
Advised on Concordia International Corp. purchases Concordia International RX (UK) Ltd. from Cinven Group Ltd., AlpInvest Partners BV
People ▾
Director
Advised on Concordia International Corp. issued Common Stock
Managing Director
Advised on Concordia International Corp. issued Common Stock
Manager
Advised on Concordia International Corp. issued Subscription Receipts
Managing Director
Advised on Concordia International Corp. issued Common Stock
Lead Manager
Advised on Concordia International Corp. issued Subscription Receipts
See 14 more listings with RelSci Professional.

Advisors & Consultants

People ▾
Advisor

Former Chief Financial Officer, Secretary & Treasurer at Concordia International Corp.

Clients

Companies ▾
   Montréal, QC
Knight Therapeutics Inc acquires, sells and markets prescription and over-the-counter pharmaceutical products. It offers commercialized Rx and OTC products, which includes Impavido, Movantik, Neuragen and Flat Tummy Tea. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montreal, Canada.
   Riyadh, RY
Saudi Chemical Co. engages in the manufacture and trade of chemical. It operates through the following segments: Explosives, Medicines and Detergents, and Production of Ammonium Nitrate. Its products include electronic detonators, blasting agents, initiation systems, seismic explosives, and accessories. The company was founded on March 25, 1972 and is headquartered in Riyadh, Saudi Arabia.
   Milan, MI
Recordati SpA engages in the research, development, manufacturing, and marketing of pharmaceuticals. It operates through two segments: Pharmaceutical and Rare Diseases. The Pharmaceutical segment offers prescription and over-the-counter products as well as chemical syntheses, intermediates, and active ingredients for its proprietary and licensed brands. The Rare Diseases segment develops, produces, and sells orphan drugs for the treatment of uncommon metabolic deficiencies of a genetic nature. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.

Key Stats and Financials as of 2016

Market Capitalization
$30.8M
Total Enterprise Value
$4.37B
Earnings Per Share
$-34.17
Revenue
$1.08B
Net Profit
$-1.74B
EBITDA
$580M
EBITDAMargin
53.59%
Total Debt
$4.76B
Total Equity
$-506M
Enterprise Value Sales
4.04x
Enterprise Value EBITDAOperating
7.54x
TEVNet Income
-2.51x
Debt TEV
1.09x
Three Year Compounded Annual Growth Rate Of Revenue
172.24%
See financial details and more using RelSci Professional.

Suppliers

   Wholesale: Consumer Non-Durables/Sundries    Tokyo, TY
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.
   Hospitals & Patient Services    Hemel Hempstead, HD
Consort Medical Plc engages in the design, development, manufacture, and sale of medical drug delivery devices. It operates through two segments: Bespak and Aesica. The Bespak segment develops and produces drug delivery devices, which serves pharmaceutical companies with inhaler and auto-injector technologies. The Aesica segment is a contract development and manufacturing organization which serves pharmaceutical firms with active pharmaceutical ingredient and finished dose formulation development and manufacturing services. The company was founded on March 22, 1946 and is headquartered in Hemel Hempstead, United Kingdom.
   Pharmaceuticals    Fontenay-sous-Bois, IF
Cenexi SASU specializes in the contract manufacturing of pharmaceuticals for humans and veterinary markets. It also manufactures solid forms (tablets and capsules), syrups, suppositories and parental ampoules for the world market. The company was founded in 2004 and is headquartered in Fontenay-sous-Bois, France.
   Holding Companies    Melsungen, HE
B. Braun Holding GmbH & Co. KG engages in the management of assets, as well as the leasing and sale of movable and immovable assets. These include land, buildings, dialysis machines, surgical equipment, and computer systems. The company is headquartered in Melsungen, Germany.
   Pharmaceuticals    Starnberg, BV
Aenova Holding GmbH provides supplies to the pharmaceutical and healthcare industries. The firm develops, produces, and markets solid dosage products such as soft and hard capsules, tablets, film-coated tablets, and effervescent tablets. Its services include production, supply chain management, packaging, support and analytics. The company was founded in 2008 and is headquartered in Starnberg, Germany.
See 1 more listing with RelSci Professional.

Competitors

   Pharmaceuticals    London, GL
Hikma Pharmaceuticals We are committed to improving people’s lives. Through our existing products and pending approvals across our markets, our aim is to provide patients with better access to high-quality, cost-effective medicines in key therapeutic areas. Our vision Our vision is to build Hikma into a world class and leading specialty pharmaceutical company, with presence across the globe. Through organic growth and by acquisitions which are aligned with our strategy, we will continue to develop the business and maintain the high standards of ethics and responsibility which are central to the way we operate.
   Pharmaceuticals    Parsippany, New Jersey
The Medicines Co We are a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. In the United States, we have three marketed products, Angiomax® (bivalirudin) for Injection, Cleviprex® (clevidipine) Injectable Emulsion, and Argatroban Injection, 50 mg per 50 mL†. We also have a pipeline of acute and intensive care hospital products in development, including three late-stage development product candidates, cangrelor, oritavancin and MDCO-157, and two early stage development product candidates, MDCO-2010 and MDCO-216. We believe that Angiomax, Cleviprex and our products in development possess favorable attributes that can satisfy unmet medical needs in the acute | intensive care hospital product market and offer, or, in the case of our products in development, have the potential to offer, improved performance to hospital businesses. The Company is publicly traded on the Nasdaq exchange under the ticker symbol MDCO. It was founded in 1996 and employs approximately 425 professionals.
   Wholesale: Consumer Non-Durables/Sundries    Port Washington, NY
Aceto functions as a virtual manufacturing company, distributing more than 1,100 chemical compounds used principally as raw materials or finished products. With business operations in nine countries, Aceto’s global reach is distinctive in the industry, enabling the Company to source and supply quality products on a worldwide basis. Leveraging local professionals, Aceto sources more than two-thirds of its products from Asia, buying from approximately 500 companies in China and 200 in India.
   Pharmaceuticals    Hayward, CA
Impax Laboratories, Inc. operates as a technology based specialty pharmaceutical company, which engages in the development, manufacture, and marketing of controlled-release and niche generics. It operates through the Impax Generics and Impax Specialty Pharma segments. The Impax Generics segment concentrates on the development manufacture, sale and distribution of generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are usually marketed under their established nonproprietary drug names rather than by a brand name. The Impax Specialty Pharma segment engages in the development of proprietary brand pharmaceutical products. The company was founded on December 14, 1999 and is headquartered in Hayward, CA.
   Pharmaceuticals    Lake Forest, Illinois
Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe. Our customers include physicians, optometrists, hospitals, surgery centers, clinics, long-term care, wholesalers, group purchasing organizations, retail pharmacies, and other pharmaceutical companies. Akorn is committed to serving our customers by providing an extensive line of affordable, safe and efficacious pharmaceuticals in the following markets: Ophthalmologic Pharmaceuticals: Solutions, Ointments, Gels, and Injectables The Company’s Ophthalmic segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes, which are used in the office setting. We also sell therapeutic products, such as antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers. In addition, this segment offers non-pharmaceutical products, including various artificial tear solutions, and preservative-free lubricating ointments. Specialty Therapeutics and Injectable Pharmaceuticals: Liquid and Lyophilized The Company's Specialty Therapeutics and Injectable segment markets hospital drug and injectable pharmaceutical products, including antidotes, anti-infectives, and controlled substances for pain management and anesthesia; and other pharmaceutical products. This segment markets products to hospitals through the wholesale distribution channel. Contract Manufacturing Our Contract Service segment manufactures aseptic filled and terminally sterilized ophthalmic and injectable pharmaceutical products from our facilities in Somerset, NJ and Decatur, IL for third party pharmaceutical customers. Akorn was founded in 1971 and is headquartered in Lake Forest, Illinois.
See 4 more listings with RelSci Professional.

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial ➤
Still not convinced? Check out our full listing of features here.